Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-03 · accession 0000950170-24-025917 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-03+ | TEVA | Sabag Mark | EVP, International Markets | M - OptEx | — | +58.4K | 367.2K | +19% | — |
| D | 2024-03-05 | 2024-03-04 | TEVA | Sabag Mark | EVP, International Markets | A - Grant | $0.00 | +74.4K | 74.4K | New | $0 |
| DM | 2024-03-05 | 2024-03-03+ | TEVA | Sabag Mark | EVP, International Markets | M - OptEx | $0.00 | -58.4K | 74.7K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-03-04 | M | A | 33,512 | — | 400,693 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2024-03-03 | M | A | 24,900 | — | 367,181 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Derivative | Restricted Share Units | 2024-03-04 | A | A | 74,404 | $0.00 | 74,404 | D | — · — to — | 74,404 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on March 4, 2024, with 18,601 vesting on each of March 4, 2025, March 4, 2026, March 4, 2027, and March 4, 2028. |
| 4 | Derivative | Restricted Share Units | 2024-03-04 | M | D | 33,512 | $0.00 | 67,024 | D | — · — to — | 33,512 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026. |
| 5 | Derivative | Restricted Share Units | 2024-03-03 | M | D | 24,900 | $0.00 | 74,701 | D | — · — to — | 24,900 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027. |